NCT05750992 Ultrasound Guided TAPB vs Surgical TAPB With Bupivacaine in Cesarean Section
| NCT ID | NCT05750992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Al-Azhar University |
| Condition | Cesarean Section |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-04-10 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-04-10 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to compare Surgical Transversus abdominis plane block and Ultrasound guided transversus abdominis plane block (TAPB) as a postoperative analgesic regimen in female patients undergoing elective cesarean delivery.
Eligibility Criteria
Inclusion Criteria: * Full term pregnant women * Older than 21 years of age * Had elective cesarean section with Pfannenstiel incision. Exclusion Criteria: * Patients with cesarean section using different surgical incision * History of addiction \[including opioids and benzodiazepines\] * Allergy to the anesthetic analgesia * Psychological disorders * Coagulopathies * Infection at the block injection site.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05750992 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 35 Years, studying Cesarean Section. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05750992 currently recruiting?
Yes, NCT05750992 is actively recruiting participants. Contact the research team at nevenabdo@azhar.edu.eg for enrollment information.
Where is the NCT05750992 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT05750992 clinical trial?
NCT05750992 is sponsored by Al-Azhar University. The trial plans to enroll 50 participants.